O.N. has received research support from Janssen and Takeda; has been an advisory board member for Bristol Myers Squibb, GPCR therapeutics, Janssen, Sanofi and Takeda; and has received honoraria from Pfizer. I.M.G. has been a paid consultant for 10X Genomics, AbbVie, Adaptive Biotechnologies, Amgen, Aptitude Health, Binding Site (part of Thermo Fisher Scientific), Bristol Myers Squibb, GlaxoSmithKline, Janssen, Menarini Silicon Biosystems, Novartis, Pfizer, Regeneron, Sanofi, Standard Biotools, and Takeda. She is a founder and board member of, and holds private equity in, Predicta Biosciences; and her spouse is the chief medical officer of, and holds private equity in, Disc Medicine.